NACDS Applauds Rejection of California State Legislation That Would Disempower Patients, Drive Up Healthcare Costs

Published Online: Friday, January 13, 2012
Follow Pharmacy_Times:
The National Association of Chain Drug Stores (NACDS) applauded the rejection of California legislation that would require a prescription for over-the-counter products containing pseudoephedrine, a key ingredient in cold and allergy medications.
 
This anti-consumer legislation (SB 315) would have mandated prescriptions for pseudoephedrine-containing products, thereby skyrocketing healthcare costs and reducing Californians’ access to health care, while not reducing the drug abuse and misuse of these products

NACDS joined state partners in California to oppose this legislation.  The Association testified before state lawmakers, highlighting community pharmacy’s commitment to working with law enforcement to help provide them access to the information they need to identify and stop this criminal activity, while ensuring patients have access to the over-the-counter medications that they rely on to treat illnesses.
 
NACDS also stressed that the prescription requirement would result in increased healthcare costs, resulting from an increase in doctors’ visits, prescription pharmacy costs, Medi-Cal costs and insurance premiums.
 
“We are pleased that California lawmakers rejected this anti-consumer legislation.  Requiring a prescription for over-the-counter products containing pseudoephedrine would be a cure worse than the disease,” said NACDS President and CEO Steven C. Anderson, IOM, CAE.  “A prescription requirement would disempower patients in their own healthcare and would only increase healthcare costs."

NACDS continues working with state and federal officials to curb pseudoephedrine misuse and abuse, emphasizing that a prescription-only approach would have detrimental impacts on patients and the healthcare system.
Related Articles
Four states are reporting recent progress on preventing pseudoephedrine diversion after implementing a real-time, stop-sale tracking system.
Availability of a raw methamphetamine ingredient in popular OTC products prompted national regulations to move products that contain pseudoephedrine behind the pharmacy counter.
The National Association of Chain Drug Stores lends its support to S. 483, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015.
The value of collaboration through the National Association of Chain Drug Stores was on display today, as the NACDS Regional Chain Conference explored business-to-business partnerships and a public policy agenda that benefits patients and consumers.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$